These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30873112)

  • 1. Retraction: Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression.
    Frontiers Editorial Office
    Front Neurol; 2019; 10():255. PubMed ID: 30873112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression.
    Zhang L; Fang Y; Cheng X; Lian YJ; Xu HL; Zeng ZS; Zhu HC
    Front Neurol; 2017; 8():531. PubMed ID: 29062301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: Genetic Variation in the Androgen Receptor and Measures of Plasma Testosterone Levels Suggest Androgen Dysfunction in Alzheimer's Disease.
    Frontiers Editorial Office
    Front Neurosci; 2019; 13():1265. PubMed ID: 31803015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.
    Pluta R; Ułamek-Kozioł M; Czuczwar SJ
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction notice for: "Schizandrin A exerts anti-tumor effects on A375 cells by down-regulating H19" [Braz J Med Biol Res (2019) 52(10): e8385].
    Braz J Med Biol Res; 2021 Jul; 54(7):e8385retraction. PubMed ID: 34320092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APP controls the formation of PI(3,5)P(2) vesicles through its binding of the PIKfyve complex.
    Currinn H; Guscott B; Balklava Z; Rothnie A; Wassmer T
    Cell Mol Life Sci; 2016 Jan; 73(2):393-408. PubMed ID: 26216398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction of "Isovitexin modulates autophagy in Alzheimer's disease via miR-107 signalling".
    Cheng J; Wang G; Zhang N; Li F; Shi L; Li H
    Transl Neurosci; 2022 Jan; 13(1):407. PubMed ID: 36447640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualization of Phosphatidylinositol 3,5-Bisphosphate Dynamics by a Tandem ML1N-Based Fluorescent Protein Probe in Arabidopsis.
    Hirano T; Stecker K; Munnik T; Xu H; Sato MH
    Plant Cell Physiol; 2017 Jul; 58(7):1185-1195. PubMed ID: 28158631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retraction: Resveratrol Preincubation Enhances the Therapeutic Efficacy of hUC-MSCs by Improving Cell Migration and Modulating Neuroinflammation Mediated by MAPK Signaling in a Mouse Model of Alzheimer's Disease.
    Frontiers Editorial Office
    Front Cell Neurosci; 2021; 15():728508. PubMed ID: 34366793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease.
    Chen M; Du ZY; Zheng X; Li DL; Zhou RP; Zhang K
    Neural Regen Res; 2018 Apr; 13(4):742-752. PubMed ID: 29722330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease [Retraction].
    Int J Clin Exp Pathol; 2018; 11(3):1837. PubMed ID: 29874341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis [Retraction].
    Cancer Manag Res; 2020; 12():5739. PubMed ID: 32765077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: Curcumin Blunts IL-6 Dependent Endothelial-to-Mesenchymal Transition to Alleviate Renal Allograft Fibrosis Through Autophagy Activation.
    Frontiers Editorial Office
    Front Immunol; 2021; 12():818539. PubMed ID: 34899767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction Note to: A novel self-nanoemulsifying drug delivery system for curcumin used in the treatment of wound healing and inflammation.
    Ahmad N; Ahmad R; Al-Qudaihi A; Alaseel SE; Fita IZ; Khalid MS; Pottoo FH; Bolla SR
    3 Biotech; 2022 Apr; 12(4):94. PubMed ID: 35371902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial.
    Agahi A; Hamidi GA; Daneshvar R; Hamdieh M; Soheili M; Alinaghipour A; Taba SME; Salami M
    Front Neurol; 2019; 10():31. PubMed ID: 30804870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro/vivo Drug Release and Anti-Diabetic Cardiomyopathy Properties of Curcumin/PBLG-PEG-PBLG Nanoparticles [Retraction].
    Int J Nanomedicine; 2021; 16():3579. PubMed ID: 34079250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction: Creation of ultrasound and temperature-triggered bubble liposomes from economical precursors to enhance the therapeutic efficacy of curcumin in cancer cells.
    Shore A
    RSC Adv; 2018 Nov; 8(69):39786. PubMed ID: 35560733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease [Retraction].
    Am J Neurodegener Dis; 2016; 5(3):152. PubMed ID: 27508109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction Note.
    Kowsar Publishing Company
    Iran Red Crescent Med J; 2016 Mar; 18(3):e43586. PubMed ID: 27830082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETRACTION:  How blockchain-timestamped protocols could improve the trustworthiness of medical science.
    Irving G; Holden J
    F1000Res; 2017; 6():805. PubMed ID: 28649375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.